Lloydspharmacy boss steps down after three years in role

The CEO of McKesson UK – Lloydspharmacy’s and AAH’s parent company – Toby Anderson has stepped down from the the role with “immediate effect”, the company has announced. 

breaking
McKesson

Mr Anderson leaves the company after almost four years as CEO, McKesson UK announced today (May 11).

Private equity firm Aurelius Group completed the acquisition of McKesson UK last month (April 7).

Commenting on Mr Anderson’s time at McKesson, Dominik Müser - who works within Aurelius's leadership team - said the company is “extremely grateful for the commitment Toby has demonstrated over the years to help us achieve the McKesson vision of becoming the UK’s leading healthcare organisation”.

“His leadership, during a period of great uncertainty, has given us the solid foundations we can now build on to deliver sustained success in the future,” Mr Müser added.

During the COVID -19 pandemic, Mr Anderson “ensured that our customers and patients could continue to receive the vital medicines and services they needed”, Mr Müser said.

He also commended Mr Anderson’s work in helping “turn around the profitability of our business”.

“We remain focussed on delivering great services for our customers and patients across our individual businesses. Through our core businesses – Lloydspharmacy, Lloydspharmacy Clinical Homecare, and AAH – we play a vital role in protecting the health of communities across the country and we have an exciting opportunity to grow and improve our businesses even more over the next few years,” Mr Müser added.

Read more: Lloyds CEO ‘implores’ government to reimburse pharmacy business rates

In a message to McKesson UK employees, seen by C+D, Mr Anderson confirmed he was stepping down as, “as part of the McKesson’s strategy to divest the European businesses, including the UK and the subsequent purchase by Aurelius, [the] whole strategy is to accelerate clearer and more direct accountability of and within our business units”.

Mr Anderson went on to thank his executive team and “all colleagues across the McKesson UK organisation, who have shown great courage and commitment in supporting our customers, patients and continuing to deliver vital services during the last couple of years, while the country has faced into the pandemic”.

“I would like to wish everyone at McKesson UK best wishes for the future, and to take this opportunity to say goodbye,” he added. 

Read more: Lloyds chief: The ‘great pain’ of deciding to close Lloyds branches

Sign in or register for free

Latest from News

Retired pharmacist crushed to death in canal boat accident

 
• By 
 • comment

Margaret Billings sustained fatal injuries when she was caught between a moving boat and a riverbank during a day out “with family and friends”, an inquest has found.

NHSE scrapped: ‘Fresh start or just more political chaos?’

 
• By 
 • comment

C+D rounds up some of the immediate pharmacy reaction to news that NHS England will be abolished, with more control moving back to the government and local leaders…

New primary care medical director role as 2-year NHSE axing begins

 
• By 
 • comment

Wes Streeting has revealed that the DH is “immediately” working to scrap NHS England (NHSE) and put a new “transformation team” in place – adding that it is in the “very final stages” of concluding a new pharmacy contract deal.

More from Business

breaking news

IN FULL: Boots’ parent company sold in $24bn private equity deal

 
• By 
 • comment

Walgreens Boots Alliance (WBA) has “entered into a definitive agreement to be acquired” by private equity firm Sycamore Partners.

Jhoots accounts: Shareholder funds tumble while debts soar

 
• By 
 • comment

Jhoots Chemist’s accounts for 2024 have revealed an almost £2 million year-on-year dip in shareholder funds – as debts to creditors increase more than £2m.